Kalpana Tilekar

Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives

Vijay Patil, Kalpana Tilekar, Sonali Mehendale-Munj et al. · European Journal of Medicinal Chemistry · 2010 · 138 citations

Derivatives, New 5-Benzylidene-2,4-thiazolidinedione, Organic Chemistry +3

Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation

Neha Upadhyay, Kalpana Tilekar, Niklas Jänsch et al. · Bioorganic Chemistry · 2020 · 48 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Biochemistry +10

Discovery of 5-naphthylidene-2,4-thiazolidinedione derivatives as selective HDAC8 inhibitors and evaluation of their cytotoxic effects in leukemic cell lines

Kalpana Tilekar, Neha Upadhyay, Niklas Jänsch et al. · Bioorganic Chemistry · 2019 · 46 citations

Selective Hdac8 Inhibitors, Medicine, 5-Naphthylidene-2,4-thiazolidinedione Derivatives +8

Current status and future prospects of molecular hybrids with thiazolidinedione (TZD) scaffold in anticancer drug discovery

Kalpana Tilekar, Onkar Shelke, Neha Upadhyay et al. · Journal of Molecular Structure · 2021 · 41 citations

Medicinal Chemistry, Bioorganic Chemistry, Polymer-drug Conjugate +10

Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy

Neha Upadhyay, Kalpana Tilekar, Fulvio Loiodice et al. · Bioorganic Chemistry · 2020 · 37 citations

Medicine, Drug Discovery, Rational Drug Design +9